Stephen R. Brady - Insider Trading & Ownership

Entity
Individual
Location
C/O Immune Design Corp., 1616 Eastlake Ave. E, Suite 310, Seattle, Washington
Summary
The estimated net worth of Stephen R. Brady is at least $97.9 K dollars as of July 8, 2024. Stephen R. Brady is the President and CEO, Director of Tempest Therapeutics, Inc. and owns shares of Tempest Therapeutics, Inc. (TPST) stock worth about $97.9 K.
All Insider Reports
All Insider Reports

Ownership of Stephen R. Brady

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TPST Tempest Therapeutics, Inc. President and CEO, Director $97.9 K +$73.9 K +308% Jul 3, 2024
BCEL Atreca, Inc. Director Jun 13, 2023

Insider Transactions Reported by Stephen R. Brady:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership